NCT07104383Phase 3Active not recruiting

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Study sponsor: Viking Therapeutics, Inc. · VKTX

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2027-07-01Estimated
Enrollment · participants1100Estimated
Source updated2026-04-07Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source